Please Wait
Applying Filters...

Annual Sales of Naldemedine reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Menu
$ API Ref.Price (USD/KG) : 86,335Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5Symproic

PharmaCompass

01

Brand Name : Symproic

Naldemedine

arrow
AAPS 2024
Not Confirmed

Brand Name : Symproic

arrow
AAPS 2024
Not Confirmed

Naldemedine

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2019 Revenue in Millions : 19

2018 Revenue in Millions : 13

Growth (%) : 43

blank

02

Brand Name : Symproic

Naldemedine

arrow
AAPS 2024
Not Confirmed

Brand Name : Symproic

arrow
AAPS 2024
Not Confirmed

Naldemedine

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 22

2019 Revenue in Millions : 19

Growth (%) : 15

blank

03

Brand Name : Symproic

Naldemedine

arrow
AAPS 2024
Not Confirmed

Brand Name : Symproic

arrow
AAPS 2024
Not Confirmed

Naldemedine

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 22

2020 Revenue in Millions : 21

Growth (%) : 13

blank

04

Brand Name : Symproic

Naldemedine

arrow
AAPS 2024
Not Confirmed

Brand Name : Symproic

arrow
AAPS 2024
Not Confirmed

Naldemedine

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2022 Revenue in Millions : 25

2021 Revenue in Millions : 22

Growth (%) : 16

blank

05

Brand Name : Symproic

Naldemedine

arrow
AAPS 2024
Not Confirmed

Brand Name : Symproic

arrow
AAPS 2024
Not Confirmed

Naldemedine

Main Therapeutic Indication : Gastrointestinal Diseases

Currency : USD

2023 Revenue in Millions : 28

2022 Revenue in Millions : 25

Growth (%) : 24

blank